BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38030063)

  • 1. A Nasal Swab Classifier to Evaluate the Probability of Lung Cancer in Patients With Pulmonary Nodules.
    Lamb CR; Rieger-Christ KM; Reddy C; Huang J; Ding J; Johnson M; Walsh PS; Bulman WA; Lofaro LR; Wahidi MM; Feller-Kopman DJ; Spira A; Kennedy GC; Mazzone PJ
    Chest; 2024 Apr; 165(4):1009-1019. PubMed ID: 38030063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
    Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
    Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
    BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a multiprotein plasma classifier to identify benign lung nodules.
    Vachani A; Pass HI; Rom WN; Midthun DE; Edell ES; Laviolette M; Li XJ; Fong PY; Hunsucker SW; Hayward C; Mazzone PJ; Madtes DK; Miller YE; Walker MG; Shi J; Kearney P; Fang KC; Massion PP
    J Thorac Oncol; 2015 Apr; 10(4):629-37. PubMed ID: 25590604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Assisted Diagnosis System for Detection of Early Pulmonary Nodule in Computed Tomography Images.
    Liu JK; Jiang HY; Gao MD; He CG; Wang Y; Wang P; Ma H; Li Y
    J Med Syst; 2017 Feb; 41(2):30. PubMed ID: 28032305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
    Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
    Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
    Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
    Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided diagnosis of lung cancer: the effect of training data sets on classification accuracy of lung nodules.
    Gong J; Liu JY; Sun XW; Zheng B; Nie SD
    Phys Med Biol; 2018 Feb; 63(3):035036. PubMed ID: 29311420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of radiomics-based predictive models in low-dose CT screening for early lung cancer diagnosis.
    Garau N; Paganelli C; Summers P; Choi W; Alam S; Lu W; Fanciullo C; Bellomi M; Baroni G; Rampinelli C
    Med Phys; 2020 Sep; 47(9):4125-4136. PubMed ID: 32488865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules.
    Wang B; Tang Y; Chen Y; Hamal P; Zhu Y; Wang T; Sun Y; Lu Y; Bhuva MS; Meng X; Yang Y; Ai Z; Wu C; Sun X
    Lung Cancer; 2020 Jan; 139():103-110. PubMed ID: 31760351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the BRODERS classifier (Benign
    Maldonado F; Varghese C; Rajagopalan S; Duan F; Balar AB; Lakhani DA; Antic SL; Massion PP; Johnson TF; Karwoski RA; Robb RA; Bartholmai BJ; Peikert T
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33303552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening.
    Tu SJ; Wang CW; Pan KT; Wu YC; Wu CT
    Phys Med Biol; 2018 Mar; 63(6):065005. PubMed ID: 29446758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.